The Mount Sinai Heart Pulmonary Hypertension Program, based at the nationally renowned Mount Sinai Hospital in New York City, is a premier, comprehensive care center for patients afflicted with pulmonary hypertension. The program consists of cardiologists, pulmonologists, and lung transplant surgeons who are leading experts in their respective fields.  We are dedicated to providing and maintaining the highest standard of acute as well as chronic care, utilizing not only proven effective treatments but also, where appropriate, new and pioneering therapy.

Better care comes directly from in-depth understanding of disease processes. This is the core belief that all physicians and scientists at the Mount Sinai Heart Pulmonary Hypertension Program hold dear. On-going research projects being performed at the Pulmonary Hypertension Program includes exploring into the molecular mechanisms of PPHTN, finding new, non-invasive imaging techniques for the evaluation of disease progression and complications, as well as searching for novel treatment regimens, such as gene therapy, for patients who are refractory to standard therapy.

Delivering top-notched medical care based on the most cutting-edged research is only one of the many services that the Mt. Sinai Pulmonary Hypertension Program has to offer. Our team of nurses, social workers, and nutritionists can help patients on the maintenance of optimal diet and activity. In addition, they also provide patients’ family with counsel and support. In fact, a Pulmonary Hypertension Support Group Meeting takes place at the Hazen Ambulatory Cardiac Care Center every month where patients and their family may get their questions answered and informal conversations with expert physicians take place.